Material changing performance
The performance of Ostapek composite
Zurich, Switzerland, 14th April 2008. A breakthrough in Ostapek built for bone technology – the Ostapek composite material for medical implants provides the high strength of metals combined with the biocompatibility and imaging advantages of polymers. Coligne’s biomaterial comprises controlled long carbon fibers in a polymer matrix and offers significantly enhanced mechanical properties. It is a clinically proven implant material, suitable for the replacement of metal implants in load-bearing spinal applications. Read all about the characteristics of Coligne’s biomaterial Ostapek composite in the company’s whitepaper “The performance of Ostapek composite”.
In high-load applications, the proven strength of Ostapek composite allows the material to be a true replacement of traditionally used metals, such as titanium alloys and stainless steel. Ostapek composite provides the necessary stiffness to achieve stabilization, combined with the desired flexibility to prevent stress shielding. The mechanical and imaging properties of Ostapek composite can be tailored to the needs of specific applications.
Polymer based implants
To resolve the problem of traditional metallic implants, which are considered to be stiffer than needed to achieve surgical fixation and correction, PEKEKK and carbon reinforced polymeric implants were developed. Mechanical properties of unreinforced PEEK are not ideal for use in rods and plates, as it may not meet the stress, shear and torque requirements of spinal implants.
Ostapek composite
Coligne’s Ostapek composite changes implant material’s performance – such as biomechanics or biocompability – due to their combination ratio, the fiber orientation and the manufacturing process. For better understanding of the unique characteristics of Coligne’s biomaterial Ostapek composite, Coligne developers introduced their whitepaper “The performance of Ostapek composite” at Coligne’s developer session 2008 in Badiola, Italy.
Contact your Coligne representative or the headquarter in Zurich, Switzerland and read all about the biomechanical properties of implant materials, the modulus of elasticity, stiffness in bending, yield strength of different materials, bending moments and the ASTM F 1717 test results.
Visit us at the Spineweek
During the Spineweek, Eurospine 2008 in Geneva, Coligne AG will present and discuss the scientific paper, introducing the characteristics of Ostapek composite.
The performance of Ostapek composite
Zurich, Switzerland, 14th April 2008. A breakthrough in Ostapek built for bone technology – the Ostapek composite material for medical implants provides the high strength of metals combined with the biocompatibility and imaging advantages of polymers. Coligne’s biomaterial comprises controlled long carbon fibers in a polymer matrix and offers significantly enhanced mechanical properties. It is a clinically proven implant material, suitable for the replacement of metal implants in load-bearing spinal applications. Read all about the characteristics of Coligne’s biomaterial Ostapek composite in the company’s whitepaper “The performance of Ostapek composite”.
In high-load applications, the proven strength of Ostapek composite allows the material to be a true replacement of traditionally used metals, such as titanium alloys and stainless steel. Ostapek composite provides the necessary stiffness to achieve stabilization, combined with the desired flexibility to prevent stress shielding. The mechanical and imaging properties of Ostapek composite can be tailored to the needs of specific applications.
Polymer based implants
To resolve the problem of traditional metallic implants, which are considered to be stiffer than needed to achieve surgical fixation and correction, PEKEKK and carbon reinforced polymeric implants were developed. Mechanical properties of unreinforced PEEK are not ideal for use in rods and plates, as it may not meet the stress, shear and torque requirements of spinal implants.
Ostapek composite
Coligne’s Ostapek composite changes implant material’s performance – such as biomechanics or biocompability – due to their combination ratio, the fiber orientation and the manufacturing process. For better understanding of the unique characteristics of Coligne’s biomaterial Ostapek composite, Coligne developers introduced their whitepaper “The performance of Ostapek composite” at Coligne’s developer session 2008 in Badiola, Italy.
Contact your Coligne representative or the headquarter in Zurich, Switzerland and read all about the biomechanical properties of implant materials, the modulus of elasticity, stiffness in bending, yield strength of different materials, bending moments and the ASTM F 1717 test results.
Visit us at the Spineweek
During the Spineweek, Eurospine 2008 in Geneva, Coligne AG will present and discuss the scientific paper, introducing the characteristics of Ostapek composite.
About coLigne
Founded in 1990, coLigne AG Zurich, headquarter Zurich, Switzerland, develops and manufactures novel and practical spinal technologies including biomaterials. coLigne supplies leading edge imlpant technology to spinal surgeons worldwide. The company developed and manufactures ostaPek biomaterial, a long carbon fiber reinforced polymer: Now a key component providing new performance to spinal treatment implants, surgical systems and procedures.
coLigne treatment technology products are manufactured in accordance with ISO 9001:2000 and ISO 13485:2003 and CFR 21 embracing the coLigne quality policy for spinal technology.
About the coAlliance
New technology requires new methods, technique and strategy. To ensure that these are properly taught and explored, coLigne founded the coAlliance, a community of like minded medical professionals devoted to the improvement of spinal treatment technology. coAlliance activities include “The Spine Surgeon’s Workshop”, which is held annually at the Medical University of Tours, France. Here experience is varied, multinational and based on the tenet, that all members have something to teach and learn. coAlliance workshops are based on participation, the exchange of competence and not hierarchy. Additional coAlliance activities include the “Developer Sessions”, “Spine Strategy Host and Guest Tours” as well as “Encrypted Video Case Discussions” between sites in Europe and the USA.
About coLigne products
All coLigne treatment technology is for use only by a qualified and trained spinal surgeon. coLigne product availability in a specific country is subject to regional health care regulation. Not all products are available in specific countries. Some products are not yet cleared by the US-FDA. Contact your coLigne representative for availability details. Consult product inserts for product warnings and details.
ostaPek®, evos™, gemitra™, trabis™, erriva™, coLigne®, the coLigne Symbol® and a strategy in spine® are trademarks of coLigne AG.
Contact
coLigne AG
Andreas Bihl
Phone +41 43 343 8000
Fax +41 43 343 8009
andreas.bihl@coligne.com
Utoquai 43
CH-8008 Zurich
Switzerland
Founded in 1990, coLigne AG Zurich, headquarter Zurich, Switzerland, develops and manufactures novel and practical spinal technologies including biomaterials. coLigne supplies leading edge imlpant technology to spinal surgeons worldwide. The company developed and manufactures ostaPek biomaterial, a long carbon fiber reinforced polymer: Now a key component providing new performance to spinal treatment implants, surgical systems and procedures.
coLigne treatment technology products are manufactured in accordance with ISO 9001:2000 and ISO 13485:2003 and CFR 21 embracing the coLigne quality policy for spinal technology.
About the coAlliance
New technology requires new methods, technique and strategy. To ensure that these are properly taught and explored, coLigne founded the coAlliance, a community of like minded medical professionals devoted to the improvement of spinal treatment technology. coAlliance activities include “The Spine Surgeon’s Workshop”, which is held annually at the Medical University of Tours, France. Here experience is varied, multinational and based on the tenet, that all members have something to teach and learn. coAlliance workshops are based on participation, the exchange of competence and not hierarchy. Additional coAlliance activities include the “Developer Sessions”, “Spine Strategy Host and Guest Tours” as well as “Encrypted Video Case Discussions” between sites in Europe and the USA.
About coLigne products
All coLigne treatment technology is for use only by a qualified and trained spinal surgeon. coLigne product availability in a specific country is subject to regional health care regulation. Not all products are available in specific countries. Some products are not yet cleared by the US-FDA. Contact your coLigne representative for availability details. Consult product inserts for product warnings and details.
ostaPek®, evos™, gemitra™, trabis™, erriva™, coLigne®, the coLigne Symbol® and a strategy in spine® are trademarks of coLigne AG.
Contact
coLigne AG
Andreas Bihl
Phone +41 43 343 8000
Fax +41 43 343 8009
andreas.bihl@coligne.com
Utoquai 43
CH-8008 Zurich
Switzerland